GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of Canada: endpoint, and what it actually costs here — 29 comments in the full submission. View in context.
1.1k
c/trialwatch·submitted 3 months ago by u/camila_vasquez

Canada: endpoint, and what it actually costs here

Trial Databranch of 6 comments

Quick one. Canada here. endpoint works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US. Specifics: the route I used took 20 weeks and cost roughly what I expected. The admin was worse than the…

Read the full submission and all 29 comments →

This branch

6 comments, started 3 months ago
u/britta_boateng57 points·3 months ago
appreciate you saying you do not know
replysharereportpermalink
u/gastric_emptying_g68 points·3 months ago

Strongly agree. Phase 2 is investigational, not conclusive.

replysharereportpermalink
u/pancreatitis_scare41 points·3 months ago

the relative risk reduction in headlines is not the whole story

replysharereportpermalink
u/cesar_ivaturi33 points·3 months ago

dropout handling matters, especially on GI-heavy populations

replysharereportpermalink
u/oskar_ibarra18 points·3 months ago

STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix

replysharereportpermalink
u/ines_boateng4 points·3 months ago

Strongly agree. Phase 2 is investigational, not conclusive.

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.